Gynazole-1, (Butoconazole Nitrate) Vaginal Cream USP, 2%, Net Wt 5.8 g per pre-filled applicator,...

FDA Drug Recall #D-0081-2024 - Class II, September 28, 2023

Recall Summary

Recall Number D-0081-2024
Classification Class II - Moderate risk
Date Initiated September 28, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Padagis US LLC
Location Minneapolis, MN
Product Type Drugs
Quantity 10,512 cartons

Product Description

Gynazole-1, (Butoconazole Nitrate) Vaginal Cream USP, 2%, Net Wt 5.8 g per pre-filled applicator, packaged in 1 prefilled applicator per carton, Rx Only, Manufactured By Padagis, Yeruham, Israel; Distributed By: Padagis, Allegan, MI 49010. NDC: 45802-396-01

Reason for Recall

Incorrect Product Formulation: Hydrophilic Colloidal Silica was used to manufacture the product rather than Hydrophobic Colloidal Silica as required by the manufacturing process.

Distribution Pattern

Nationwide within the United States

Lot / Code Information

Lot#: 164185, Exp. Date 4/2024

Other Recalls from Padagis US LLC

Recall # Classification Product Date
D-0677-2026 Class II Nystatin Cream USP, (100,000 USP Nystatin Units... Jun 23, 2026
D-0246-2025 Class II Estradiol Gel, 0.1%, 0.25 mg/g, 30 packets per ... Feb 6, 2025
D-0048-2025 Class III Triamcinolone Acetonide Cream USP, 0.025%, 1 LB... Oct 11, 2024
D-0139-2024 Class II Trospium Chloride Extended-Release Capsules, 60... Nov 1, 2023
D-0464-2023 Class III Evamist (estradiol transdermal spray), 1.53 mg ... Feb 21, 2023

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping, abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications, even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications, use a drug take-back program.